Treating obese mice with celastrol, a drug known to promote apoptosis in cancer cells via activation of IRE1, ATF4, and CHOP, reduces airway hyperresponsiveness and IL-17 production [185,187,188,189]. This evidence concerns the gene DDIT3 and airway hyperresponsiveness.